Non-Nutrient/Non-Botanical

Proteolytic Enzymes

by Adaptogen Research · Tablet or Pill

Supplement facts from the label of Proteolytic Enzymes by Adaptogen Research: Proteolytic Enzyme Blend 390 mg….

Serving size1–6 Tablet(s)
Servings per container90
Most servings a day on the label3
TypeNon-Nutrient/Non-Botanical
Barcode828054768543
Label recordDSLD 247248 · entered 2021-05-22

Supplement Facts

IngredientPer serving% DVUpper limit (adults)
Proteolytic Enzyme Blend390 mg——
└ Serratia Peptidase (Serratia marcescens)0.00 NP——
└ Bromelain (Pineapple Enzyme)0.00 NP——
└ Papain (Papaya Enzyme)0.00 NP——
└ Catalase (Aspergillus niger)0.00 NP——

Upper limits: NIH ODS Fact Sheets for Health Professionals. Compared only where the unit converts and the limit applies to the form on the label.

On the label

For: Adult (18 - 50 Years)

Claim types: All Other

Formulation re: Other: Broad systemic support

All Other Content: Professional Use Only

Precautions re: All Other: Report any adverse reactions (302) 213-0030

Formulation re: Does NOT Contain: Free of the following common allergens: milk/casein, eggs, fish, shellfish, tree nuts, peanuts, wheat, and soybeans. Contains no artificial colors, flavors, or preservatives.

Suggested/Recommended/Usage/Directions: Suggested Use: 1 tablet, 1 to 3 times daily between meals. Intensive support: 3 to 6 tablets daily between meals or as directed by a healthcare professional.

Brand IP Statement(s) re: (c), (TM), (SM): Peptizyme SP is a registered trademark of Specialty Enzymes and Biotechnologies.

This page repeats what the label says and the official upper limits for healthy adults. It is not medical advice: ask a doctor, pharmacist or registered dietitian about your own intake, especially if you are pregnant, take medicines or have a health condition.

Label data: NIH Office of Dietary Supplements, Dietary Supplement Label Database (dsld.od.nih.gov), public domain. Upper limits: NIH ODS Fact Sheets for Health Professionals (values from the Institute of Medicine, Food and Nutrition Board).